The first two Sickle Cell Disease patients admitted to the Sickle Cell Foundation of Nigeria/Lagos University Teaching Hospital, SCFN/LUTH, Bone Marrow Transplant Centre in Lagos, have been discharged and are under observation.
The patients, one paediatric and one adult, successfully underwent the first-of-its-kind Bone Marrow Transplant, BMT, in Nigeria and West Africa, heralding a groundbreaking achievement for Nigerian healthcare.
The feat was achieved at the state-of-the-art Centre following weeks of meticulous care and preparation, including chemotherapy, blood transfusions, and bone marrow stem cells harvested from family donors, then infused into the patients.
With this achievement, the SCFN in partnership with LUTH is the first non-profit organisation in Africa to lead a comprehensive bone marrow transplant initiative for sickle cell disorder.
The milestone marks a significant step forward in the treatment of sickle cell disease and other blood disorders and positions Nigeria as a hub in West Africa for advanced medical care particularly in hematology-oncology.
The Centre, equipped with advanced technology and staffed by highly skilled medical professionals, provides a comprehensive range of services for patients undergoing bone marrow transplants, even as no less than 127 potentially qualified patients are lined up to undergo the procedure.
The achievement is particularly significant for Nigeria, which has one of the highest burdens of SCD globally. Before the establishment of the center, Nigerian patients seeking bone marrow transplants had no option but to seek treatment abroad, often incurring significant costs and facing challenges related to access and affordability.
One of the mothers of the discharged patients said, “Our Bone Marrow Transplant experience has been remarkable, filled with hope and certainty. I felt confident in the exceptional care we received at the Sickle Cell Foundation Nigeria/LUTH BMT Centre. From the moment of admission to discharge, the medical staff provided round-the-clock attention,” said the mother of one of the discharged patients.
To address these challenges, Afolabi said SCFN is currently developing the Access to Care Programme, a digital platform that connects sponsors with patients in need of financial support, while transparently tracking funding and treatment progress.
